Evidence map›Paper›PMID 22949308›Full record

ArticleThe Journal of infectious diseases2012

Impaired hepatitis C virus (HCV)-specific interferon-γ responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell counts.

Jacqueline K Flynn, Gregory J Dore, Gail Matthews, Margaret Hellard, Barbara Yeung, William D Rawlinson, Peter A White, John M Kaldor, Andrew R Lloyd, Rosemary A Ffrench and 1 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in The Journal of infectious diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. HCV and HIV co-infection: mechanisms and management.Nature reviews. Gastroenterology & hepatology · 2014
    Review
  8. Article
  9. Article
  10. Article
  11. Hepatitis C Virus and HIV Type 1 Co-Infection.Infectious disease reports · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Jacqueline K FlynnCentre for Immunology, Burnet Institute, Monash University, Melbourne, Australia.
Gregory J Dore
Gail Matthews
Margaret Hellard
Barbara Yeung
William D Rawlinson
Peter A White
John M Kaldor
Andrew R Lloyd
Rosemary A Ffrench
ATAHC Study Group
Institute of Infection and Immunity · CABurnet Institute · AUSouth Eastern Sydney Local Health District · AUUNSW Sydney · AU

Funding

PHS HHS R01 15999-01
6 · The paper itself

Abstract

Studies examining the effect of coinfection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) on the HCV-specific immune response in acute HCV infection are limited. This study directly compared acute HCV-specific T-cell responses and cytokine profiles between 20 HIV/HCV-coinfected and 20 HCV-monoinfected subjects, enrolled in the Australian Trial in Acute Hepatitis C (ATAHC), using HCV peptide enzyme-linked immunospot (ELISPOT) and multiplex in vitro cytokine production assays. HIV/HCV coinfection had a detrimental effect on the HCV-specific cytokine production in acute HCV infection, particularly on HCV-specific interferon γ (IFN-γ) production (magnitude P = .004; breadth P = .046), which correlated with peripheral CD4(+) T-cell counts (ρ = 0.605; P = .005) but not with detectable HIV viremia (ρ = 0.152; P = .534).

Indexed as

CD4 Lymphocyte CountAdolescentAdultAustraliaCohort StudiesCoinfectionCytokinesEnzyme-Linked Immunospot AssayFemaleHepacivirusHepatitis CHIV InfectionsHumansInterferon-gammaInterleukin-2MaleCytokinesInterferon-gammaInterleukin-2

Identifiers

PMID22949308
PMCPMC3475632
OpenAlexW2128089251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.